The tumor suppressor Trp53 is a gatekeeper that checks the balance between proliferation and apoptosis, and its inhibition plays a crucial role in the reprogramming of cultured PGCs as downstream targets of the PI3K-Akt (Kimura et al., 2008). The gene discussed is TP53; the disease is neoplasm.